Top Markets
#1 MowCat MowCat +49.40%
#2 aPriori aPriori +32.37%
#3 Velvet Velvet +25.51%
#4 Bitway Bitway +21.02%
#5 OVERTAKE OVERTAKE +15.64%
#6 Derive Derive +15.56%
#7 Bermuda Shorts Bermuda Shorts +14.63%
#8 Merlin's Seal BTC Merlin's Seal BTC +13.49%
#9 Palladium Network Palladium Network +13.27%
#10 Perle Perle +13.07%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Integrated BioPharma, Inc. Integrated BioPharma, Inc.

Integrated BioPharma, Inc.

INBP
Classifica tra le azioni #34626
Integrated BioPharma, Inc., together with its subsidiaries, engages in the... Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Prezzo delle azioni
$0.16795
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$5.22M
Variazione (1 giorno)
4.97%
Variazione (1 anno)
-37.80%
Paese
US
Scambia Integrated BioPharma, Inc. (INBP)

Categoria

Healthcare
Rapporto P/S per Integrated BioPharma, Inc. (INBP)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Integrated BioPharma, Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Integrated BioPharma, Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US